• Subscribe
    • Sign up for updates about the journal.
  • Sign in
  • Register
Exploration of Targeted Anti-tumor Therapy
  • About
    • About the Journal
    • Editorial Board
    • Editorial Policies
    • Newsletter
    • Contact Us
  • Articles
    • Current Issue
    • Archives
  • Special Issue
    • All Special Issues
    • Guest Editor Guidelines
  • For Authors
    • Author Instructions
    • Editorial Process
    • Article Processing Charge
    • Submit a Manuscript
  • For Reviewers
    • Peer Review Guidelines
    • Reviewer Acknowledgment
    • To Be a Reviewer
  • Focus
  • Home
  • Exploration of Targeted Anti-tumor Therapy
  • Special Issues
  • Special Issue Topic

    Novel Strategies and Targets for Immunotherapy of Cancer

    Submission Deadline: September 30, 2023

    Guest Editor

    Prof. Seiji Okada E-Mail

    Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection & Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Research Keywords: Targeting therapy; cancer immunotherapy; precision medicine; animal model; Patient-derived xenograft (PDX)


    About the Special Issue

    Immunotherapy is a type of cancer treatment that helps the patients’ immune system to fight with cancer by boosting the power of immune cells. Immunotherapy used to be the way to nonspecifically activate immune system by cytokines or immune stimulants such as BCG, and it was just an adjunctive therapy of surgery, chemotherapy and radiotherapy. Recently, immunotherapy is becoming the main actor of cancer therapy by developing various therapeutic approaches and therapies such as monoclonal antibodies, immune check point inhibitors, T-cell transfer therapy such as CAR-T therapy, etc. Immune system modulators such as interferons are also clinically in use and effective in some sort of cancers. These immunotherapies still have ample scope for improvement. The aim of this special issue is to discuss the latest progress and future direction of cancer immunotherapy. We accept original research articles, critical review papers and commentaries that provide novel approaches and highlight the promising targets for cancer immunotherapies.

    Keywords: Immunotherapy; CAR-T; therapeutic monoclonal antibodies; immunomodulators; treatment vaccines; immune checkpoint inhibitors

    Call for Papers

    Published Articles

    • Submit a Manuscript
    • Aims and Scope
    • Editorial Board
    • Author Instructions
    • Ongoing Special Issues
      Off-Label Drugs and -Omics Data in Cancer Treatment
      COVID-19 and Cancer
      Antibody-Drug Conjugates
      The Role of Bcl-2 Family Proteins in Cancer Progression and Their Relevance to Cancer Therapy
      Gene Delivery Approach to Fight Cancer
      The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor
      Cancer Immunotherapy and Tumor Microenvironment
      Theranostic Frontiers in Neuro-Oncology
      Plant Extracts as an Infinite Resource for New Anticancer Agents
      Cancer Stem Cell Targeting Therapy
      Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
      Artificial Intelligence for Precision Oncology
      Innovative Strategies to Target Triple-negative Breast Cancer
      DNA Damage as Target for Therapeutic Intervention
      Therapeutic Targeting of the Tumor Microenvironment
      Molecular Targeted Therapy for Cancer
      Novel Strategies and Targets for Immunotherapy of Cancer
      Molecular Diagnosis and Personalized Therapy of Cancer
      Recent Approaches in Tumor Metabolism
      Novel Insights into Immunotherapy Targeting Tumor Microenvironment in Cancer
      Emerging Screening Technologies in Drug Discovery
      Integrated Approaches for Non-Small-Cell Lung Cancer
      Posttranslational Modifications in Health and Disease
      Therapeutic Targeting of Tumor Metabolism
      Cancer Epigenetics: Implications for Novel Therapeutic Strategies
      Current Innovative Cancer Treatment
    • Completed Special Issues
      Liquid Biopsy in Thoracic Cancer
      Targeting Transcription Factors for Cancer Therapy
      Immunotherapy in Cancer Patients
      Calcium Signaling Apparatus in Cancers
      Proteolysis Targeting Chimera (PROTAC)
      Precision Medicine for Cholangiocarcinoma
      Endocrine Resistant Breast Cancer
    • Guest Editor
    • About the Special Issue
    • Call for Papers
    • Published Articles
    • Exploration of Targeted Anti-tumor Therapy
    • eISSN 2692-3114
    • etatjournal@explorationpub.com
    • About the Journal
    • Author Instructions
    • Editorial Board
    • Editorial Policies
    • Editorial Process
    • Follow the Journal
    • JOURNALS
    • Exploration of Medicine
    • Exploration of Targeted Anti-tumor Therapy
    • Exploration of Immunology
    • Exploration of Neuroprotective Therapy
    • Exploration of Digestive Diseases
    • Exploration of Neuroscience
    • Exploration of Musculoskeletal Diseases
    • Exploration of Asthma & Allergy
    • Exploration of Drug Science
    • Exploration of Foods and Foodomics
    • Exploration of BioMat-X
    • Exploration of Digital Health Technologies
    • Exploration of Cardiology
    • Exploration of Endocrine and Metabolic Disease
    • ABOUT
    • Company Information
    • Open Access
    • Editorial Policies
    • Peer Review Policy
    • Contact Us
    • FOLLOW
    • Terms of Service Privacy Cookies
Copyright © 2023 Open Exploration Publishing Inc.